Mediven proudly participated in the 33rd ECCMID 2023, held from 15–18 April 2023 at the Bella Center Copenhagen, Denmark. As one of the leading global events in clinical microbiology and infectious diseases, ECCMID gave us the opportunity to connect with healthcare professionals, researchers, and partners from around the world.
Mediven’s Highlighted Technologies
At ECCMID 2023, Mediven showcased a powerful portfolio of diagnostic tools designed to support timely, accurate, and accessible healthcare across diverse settings:
1.GenoAmp® Molecular Diagnostics Platform
GenoAmp® drew strong interest for its robust real-time PCR technology, capable of detecting a wide range of pathogens with high sensitivity and specificity. With multiplex capabilities and reliable performance, GenoAmp® enable rapid turnaround, high sensitivity, and compliance with international clinical standards, helping clinicians make faster, informed decisions in outbreak and routine settings.
2. ProDetect® Rapid Test Kits
Our ProDetect® line received praise for its practicality and clinical value. These lateral flow immunoassays offer fast, accurate detection for diseases like COVID-19, dengue, and influenza, as well as drug screening. Designed for ease of use in both healthcare and point-of-care settings, ProDetect® continues to be a trusted solution for immediate diagnostic needs.
3. Propatch® Stay Cool
Bringing a refreshing twist to wellness, Propatch® Stay Cool was another highlight at ECCMID. This innovative cooling patch provides long-lasting, drug-free relief and is ideal for managing heat discomfort, minor fevers, or post-workout recovery. Attendees appreciated its discreet, comfortable design and consistent performance.
A Global Platform for Impact
ECCMID 2023 was an exceptional opportunity for Mediven to engage with international partners, share insights, and explore collaborative ventures. Our team was thrilled by the positive feedback and growing interest in our products from global distributors, clinicians, and laboratory professionals.
Mediven remains committed to enhancing health outcomes through accessible, effective, and innovative solutions in diagnostics and wellness. We thank ECCMID for the opportunity to be part of this influential gathering and look forward to advancing global health, one solution at a time.
